MedTrace Logo

Cell Free DNA and Its Integrity Using ALU Sequences as a Biomarker for Diagnosis of Breast Cancer

NCT03474016 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 116

Last updated 2018-05-21

No results posted yet for this study

Summary

Breast cancer (BC) is the most common cancer in women worldwide, and is the leading cause of death from cancer among women globally. Mammography is the standard method for early detection of BC in many countries, with over 1.3 million annually new diagnosed cases.In Egypt, breast cancer is the most common cancer in females accounting for 38.8% of all female cancers.

Conditions

Interventions

DIAGNOSTIC_TEST

Mammography-Histopathological examination of breast mass specimens- polymerase chain reaction

Mammography-Histopathological examination of breast mass specimens-Detection of long and short DNA fragments in serum using real-time quantitative polymerase chain reaction

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
19 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-31
Primary Completion
2020-01-31
Completion
2020-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03474016 on ClinicalTrials.gov